Page last updated: 2024-08-25

rosiglitazone and Gulf War Syndrome

rosiglitazone has been researched along with Gulf War Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gerzanich, V; Ivanova, S; Keledjian, K; Kim, K; Moyer, M; Negoita, S; Semick, S; Simard, JM; Tsymbalyuk, O	1

Other Studies

1 other study(ies) available for rosiglitazone and Gulf War Syndrome

Article	Year
The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness. PloS one, 2020, Volume: 15, Issue:11 Topics: Animals; Anxiety; Astrocytes; Brain; Cognition; Disease Models, Animal; Female; Hippocampus; Lipopolysaccharides; Male; Persian Gulf Syndrome; PPAR gamma; Pyridostigmine Bromide; Rats; Rats, Wistar; Rosiglitazone; Stress, Psychological	2020

Article

Year

The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness.

PloS one, 2020, Volume: 15, Issue:11

Topics: Animals; Anxiety; Astrocytes; Brain; Cognition; Disease Models, Animal; Female; Hippocampus; Lipopolysaccharides; Male; Persian Gulf Syndrome; PPAR gamma; Pyridostigmine Bromide; Rats; Rats, Wistar; Rosiglitazone; Stress, Psychological

2020